{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:30:04Z","timestamp":1790789404170,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"crossref","award":["94478"],"award-info":[{"award-number":["94478"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Evaluate the ability of biorelevant media to adequately predict solubility in human gastrointestinal aspirates collected in the fasted state for the sodium salt of a highly dosed, Biopharmaceutics Classification System II (BCS II) compound with weakly acidic properties (L-870,810, pKa 7.3, HA (5-(1,1-dioxothiazinan-2-yl)-N-((4-fluorophenyl)methyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide)). Identify key luminal processes that dictate the behaviour of sodium salt of HA (NaA), after single-dose administrations of high (relatively to solubility limit) doses corresponding to 400 and 800 mg of HA in the fasted state.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Aspirates from stomach and upper small intestine were collected from eight healthy fasted adults, after administration of 240 ml of water. Solubilities of NaA and HA were measured in aspirated samples and biorelevant media. Dissolution experiments of NaA granules were performed in biorelevant media. Prediction of oral pharmacokinetics was evaluated in silico using Stella software.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Equilibrium solubility of NaA in fluids aspirated from the upper gastrointestinal tract is more transient than of HA. Solubility in upper gastrointestinal lumen was adequately estimated by data in biorelevant media. Supersaturation, followed by precipitation, which did not fully revert to the equilibrium solubility of HA, was observed during the dissolution of NaA granules in biorelevant media. Physiologically based pharmacokinetic modelling indicated that while intragastric processes had no significant impact on absorption kinetics, dissolution kinetics, kinetic solubility, radial transport rates and, for the 800-mg dose, precipitation kinetics in the small intestine had the greatest impact on absorption profiles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adequate prediction of the average plasma profile, after administration of NaA, required consideration of region-dependent dissolution rates and\/or solubilisation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.12320","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T01:53:29Z","timestamp":1411523609000},"page":"56-67","source":"Crossref","is-referenced-by-count":28,"title":["Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example"],"prefix":"10.1093","volume":"67","author":[{"given":"Orestis","family":"Petrakis","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, National & Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, National & Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Angelou","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, National & Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippos","family":"Kesisoglou","sequence":"additional","affiliation":[{"name":"Pharmaceutical R&D, Merck Research Laboratories , West Point, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Bentz","sequence":"additional","affiliation":[{"name":"Pharmaceutical R&D, Merck Research Laboratories , West Point, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Goumas","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Red Cross Hospital , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Reppas","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, National & Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"2024103012483966900_jphp12320-cit-0001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/B:PHAM.0000016242.48642.71","article-title":"The \u2018high solubility\u2019 definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs","volume":"21","author":"Yazdanian","year":"2004","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0002","volume-title":"Proposal to waive in vivo bioequivalence requirements for WHO model list of essential medicines immediate-release, solid oral dosage forms, annex 8","author":"WHO","year":"2006"},{"key":"2024103012483966900_jphp12320-cit-0003","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1011071401306","article-title":"Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration","volume":"18","author":"Nicolaides","year":"2001","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0004","first-page":"446","article-title":"Blood levels following oral administration of different preparations of novobiocin","volume":"8","author":"Furesz","year":"1958","journal-title":"Antibiot Chemother"},{"key":"2024103012483966900_jphp12320-cit-0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jps.2600510603","article-title":"Influence of the absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans","volume":"51","author":"Nelson","year":"1962","journal-title":"J Pharm Sci"},{"key":"2024103012483966900_jphp12320-cit-0006","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/jps.2600570809","article-title":"Dissolution kinetics of drugs in human gastric juice \u2013 the role of surface tension","volume":"57","author":"Finholt","year":"1968","journal-title":"J Pharm Sci"},{"key":"2024103012483966900_jphp12320-cit-0007","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/jm701032y","article-title":"Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database","volume":"50","author":"Paulekuhn","year":"2007","journal-title":"J Med Chem"},{"key":"2024103012483966900_jphp12320-cit-0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","article-title":"PBPK models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"2024103012483966900_jphp12320-cit-0009","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1208\/s12248-013-9519-x","article-title":"Incorporation of physiologically based pharmacokincetic modelling in the evaluation of solubility requirements for the salt selection process: a case study using phenytoin","volume":"5","author":"Chiang","year":"2013","journal-title":"AAPS J"},{"key":"2024103012483966900_jphp12320-cit-0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012483966900_jphp12320-cit-0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2012.01.017","article-title":"Supersaturation in human gastric fluids","volume":"81","author":"Bevernage","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012483966900_jphp12320-cit-0012","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11095-013-0974-y","article-title":"Design of biorelevant test setups for the prediction of diclophenac in vivo features after oral administration","volume":"30","author":"Guhmann","year":"2013","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0013","volume-title":"National Center for Biotechnology Information","author":"PubChem Compound Database","year":"2005"},{"key":"2024103012483966900_jphp12320-cit-0014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0015","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1194\/jlr.D800039-JLR200","article-title":"Determination of intralumenal individual bile acids by HPLC with charged aerosol detection","volume":"49","author":"Vertzoni","year":"2008","journal-title":"J Lipid Res"},{"key":"2024103012483966900_jphp12320-cit-0016","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012483966900_jphp12320-cit-0018","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejpb.2011.10.004","article-title":"In vitro vs canine data for assessing early exposure of doxazosin base and its mesylate salt","volume":"80","author":"Erceg","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012483966900_jphp12320-cit-0019","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0020","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0021","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-014-1306-6","article-title":"Feasibility of capsule endoscopy for direct imaging of drug delivery systems in the fasted upper-gastrointestinal tract","author":"Pedersen","year":"2014","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0022","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/mp2002818","article-title":"Comparison and analysis of theoretical models for diffusion-controlled dissolution","volume":"9","author":"Wang","year":"2012","journal-title":"Mol Pharmaceut"},{"key":"2024103012483966900_jphp12320-cit-0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1016010207729","article-title":"Effect of change in shape factor of a single crystal on its dissolution behaviour","volume":"13","author":"Dali","year":"1996","journal-title":"Pharm Res"},{"issue":"Suppl. 1","key":"2024103012483966900_jphp12320-cit-0024","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"2024103012483966900_jphp12320-cit-0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"key":"2024103012483966900_jphp12320-cit-0026","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11095-006-0207-8","article-title":"Canine intestinal contents vs simulated media for the assessment of solubility of two weak bases in the human small intestinal contents","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0027","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.2042-7158.1986.tb04501.x","article-title":"The effect of pH and concentration on alpha-methyldopa absorption in man","volume":"38","author":"Merfeld","year":"1986","journal-title":"J Pharm Pharmacol"},{"key":"2024103012483966900_jphp12320-cit-0028","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.2042-7158.1987.tb03434.x","article-title":"Common ion effect on solubility and dissolution rate of the sodium salt of an organic acid","volume":"39","author":"Serajuddin","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"2024103012483966900_jphp12320-cit-0029","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1021\/jm901846t","article-title":"How well can the Caco-2\/Madin-Darby canine kidney models predict effective human jejunal permeability?","volume":"53","author":"Avdeef","year":"2010","journal-title":"J Med Chem"},{"key":"2024103012483966900_jphp12320-cit-0030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test","volume":"23","author":"Takano","year":"2006","journal-title":"Pharm Res"},{"key":"2024103012483966900_jphp12320-cit-0031","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2009.05.009","article-title":"Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modelling","volume":"73","author":"Shono","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012483966900_jphp12320-cit-0032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/mp800148u","article-title":"Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers","volume":"6","author":"Sheng","year":"2009","journal-title":"Mol Pharm"},{"key":"2024103012483966900_jphp12320-cit-0033","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpb.2013.10.017","article-title":"Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness","volume":"86","author":"Markopoulos","year":"2014","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12320","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12320","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/1\/56\/60227790\/jphp12320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/1\/56\/60227790\/jphp12320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:10:43Z","timestamp":1730311843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/67\/1\/56\/6128131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,1]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.12320","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,1]]},"published":{"date-parts":[[2015,1,1]]}}}